TCL Archive NCI, NCAB Consider Moving Basic Science Centers Out Core Grant Pool, Into Research Programs February 10, 1989
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO. July 14, 2006